Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.
Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P.
Schjesvold FH, et al. Among authors: sandberg a.
Haematologica. 2024 Feb 29. doi: 10.3324/haematol.2023.284635. Online ahead of print.
Haematologica. 2024.
PMID: 38426292
Free article.